Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

This Future Clinical Endpoint Could Make An Instant Blockbuster Out Of Viking's VK5211 [Seeking Alpha]

Viking Therapeutics, Inc. (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
Company Research Source: Seeking Alpha
This Future Clinical Endpoint Could Make An Instant Blockbuster Out Of Viking's VK5211SummaryHip fracture is a serious and growing healthcare problem that is in desperate need of focus.1-year mortality rates in patients post hip fracture repair are high and need to be addressed.Improvements in mobility post hip fracture repair is reasonably likely to improve 1-year mortality rates.I propose Viking Therapeutics and the FDA should adopt phase 3 clinical endpoints to include mobility and mortality.If VK5211 is able to improve mobility and mortality, it will be an instant blockbuster. Show less Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VKTX alerts
Opt-in for
VKTX alerts

from News Quantified
Opt-in for
VKTX alerts

from News Quantified